Profound Medical (PROF) Long-Term Deferred Tax (2024 - 2026)
Profound Medical's (PROF) quarterly Long-Term Deferred Tax came in at $68000.0 in Q1 2026, down 21.84% year-on-year from $87000.0 in Q1 2025, and up 3.03% quarter-over-quarter from $66000.0 in Q4 2025.
Profound Medical (PROF) Long-Term Deferred Tax (2024 - 2026) Analysis & Trends
Profound Medical's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $68000.0 for Q1 2026.
- On a quarterly basis, Long-Term Deferred Tax fell 21.84% year-over-year to $68000.0 in Q1 2026; TTM through Mar 2026 was $68000.0, a 21.84% decrease from a year earlier, with the FY2025 full-year figure at $66000.0, down 24.14% from the prior year.
- Long-Term Deferred Tax advanced to $68000.0 in Q1 2026 per PROF's latest filing, from $66000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $101000.0 in Q2 2025 and bottomed at $66000.0 in Q4 2025.
- The 3-year median for Long-Term Deferred Tax is $83500.0 (2024), against an average of $81500.0.
- Across the five-year window, Long-Term Deferred Tax declined 24.14% in 2025 and retreated 21.84% in 2026, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $87000.0 in 2024, then fell by 24.14% to $66000.0 in 2025, then advanced by 3.03% to $68000.0 in 2026.
- Per Business Quant, the three latest PROF Long-Term Deferred Tax figures stand at $68000.0 (Q1 2026), $66000.0 (Q4 2025), and $80000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 101,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 87,000.00 |